shannah
Senior Member
- Messages
- 1,429
Dec. 27: Statement from the Blood XMRV Scientific Working Group
by The CFIDS Association of America on Monday, December 27, 2010 at 11:52am
The Blood XMRV Scientific Research Working Group has discussed the findings from the four studies published in Retrovirology on December 20, 2010. These studies confirmed the importance of carefully checking XMRV/MLV related-positive results for any evidence of contamination with mouse genetic materials. The Working Group is proceeding with phase III which will evaluate the clinical sensitivity and specificity of multiple laboratory assays that test for the RNA and/or DNA of XMRV/MLVs or antibodies to these viruses. All laboratories have and will continue to apply best practices and check to the best of their ability that no contamination with mouse DNA is present before reporting any positive results. These reports also substantiate the importance of employing tests that not only detect viral DNA and/or RNA but can also detect the virus itself (culture) and/or an immunological reaction to the virus. These tests are reflected in the Working Group planned phase III study."
For more information about the Blood XMRV Scientific Research Working Group and its studies, please view our webinar recording from Dec. 17, 2010 at http://www.youtube.com/watch?v=0HynlkG0cVc that provides an overview of the studies planned and data accumulated so far.
http://www.facebook.com/notes/the-c...rv-scientific-working-group/10150116408850539
by The CFIDS Association of America on Monday, December 27, 2010 at 11:52am
The Blood XMRV Scientific Research Working Group has discussed the findings from the four studies published in Retrovirology on December 20, 2010. These studies confirmed the importance of carefully checking XMRV/MLV related-positive results for any evidence of contamination with mouse genetic materials. The Working Group is proceeding with phase III which will evaluate the clinical sensitivity and specificity of multiple laboratory assays that test for the RNA and/or DNA of XMRV/MLVs or antibodies to these viruses. All laboratories have and will continue to apply best practices and check to the best of their ability that no contamination with mouse DNA is present before reporting any positive results. These reports also substantiate the importance of employing tests that not only detect viral DNA and/or RNA but can also detect the virus itself (culture) and/or an immunological reaction to the virus. These tests are reflected in the Working Group planned phase III study."
For more information about the Blood XMRV Scientific Research Working Group and its studies, please view our webinar recording from Dec. 17, 2010 at http://www.youtube.com/watch?v=0HynlkG0cVc that provides an overview of the studies planned and data accumulated so far.
http://www.facebook.com/notes/the-c...rv-scientific-working-group/10150116408850539